Lauren Weddleton has joined Ultromics as Territory Manager for New England! Lauren brings two decades of experience in the medical device industry, including roles at Atrium Medical, Nonin, and Cardiva Medical. Find out more or connect with Lauren: https://t.co/8sASFW2zpK

❤️ We’re going red at #AHA25! Today, the Ultromics team is proud to stand with the cardiovascular community in driving progress in the detection and management of heart disease. 📍 Visit us at Booth 3319 to learn how Ultromics' AI-powered solutions are transforming cardiac care

At #AHA25, we are continuing conversations on innovation in cardiovascular care — learn more about our advances in using AI for heart failure detection at Booth 3319. Dr. Andres Schuster recently shared how EchoGo® Heart Failure helps detect #HFpEF: https://t.co/BjhVYy9t6O

#AHA25 Ultromics CEO & Founder @DrRossUpton on stage in 'Clinically Vetted AI in Action', exploring how AI is changing the way we detect and treat heart disease. Ultromics AI solutions are live in U.S. hospitals & supported through reimbursement: https://t.co/BRI9sVofk4 #EchoGo

1 hour to go until our CEO & Founder @DrRossUpton takes the stage at #AHA25 for “Clinically Vetted AI in Action”. He’ll join Dr. Lee Schwamm to discuss how AI is advancing the future of cardiovascular care. #EchoGo 📍 Health Innovation Pavilion 🕐1 PM

Excited to be back at #AHA25, showcasing how Ultromics is expanding AI solutions to make early heart failure detection part of routine cardiac care, from a single echo. Our incredible team is representing Ultromics throughout the conference at booth 3319.

We’re at #AHA25 in New Orleans! Visit us at booth 3319 👋 Tomorrow, we’ll share how Ultromics is using AI to advance detection of HFpEF and cardiac amyloidosis. 📢Ultromics in “Clinically-Vetted AI in Action” with @DrRossUpton Sat, Nov 8 | 1:00 PM Health Innovation Pavilion

We’re excited to welcome Scott Ambrose as Vice President, National Accounts! Scott will lead initiatives to expand access to Ultromics across the U.S., advancing our mission to improve early detection of heart failure Find out more or connect with Scott: https://t.co/nRKhhx21K7

A warm welcome to Jessica Kenney who joins Ultromics as Customer Success Account Executive! Jessica brings 10+ years of cardiovascular experience, most recently at Abbott, where she led digital innovation. Find out more or connect with Jessica here: https://t.co/ujYgsd8eQX

Ultromics will be at #AHA25 next week! Our CEO @DrRossUpton will join the session “Clinically-Vetted AI in Action” to share how Ultromics is advancing cardiac care through AI and echocardiography and improving early detection of heart failure. Hear from Ultromics: 🗓️

This #WorldAmyloidosisDay, we’re raising awareness of early diagnosis. Survival has improved with new treatments, but early detection remains critical. Ultromics is driving innovation to help identify cardiac amyloidosis & connect patients to treatment. https://t.co/OHrek6kjqJ

Join Ultromics CEO Ross Upton and experts from UPMC, UT Southwestern Medical Center, and Beth Israel Deaconess Medical Center on 10/23 for an important session: "Earlier, Smarter, Better: Transforming Heart Failure Diagnosis with AI"! Register today! 🔗 https://t.co/iq7UADQGyW

“I’m now getting referrals from colleagues saying, ‘I don’t really see anything, but the algorithm is reporting amyloidosis,’” — Dr. Faizi A. Jamal (@CityofHope) on how EchoGo® Amyloidosis is supporting detection and referrals. ▶️ Watch: https://t.co/xRh1z0hxeR #CardioTwitter

Lead author Jeremy A. Slivnick (@UChicago) on the training, validation & testing of EchoGo® Amyloidosis — published in European Heart Journal. EchoGo® Amyloidosis uses AI to detect cardiac amyloidosis from a single apical 4-chamber echo view. ▶️ Watch: https://t.co/XCdzDIlhue

Watch @pattypellikka (Mayo Clinic) discuss the training, validation, and testing behind EchoGo® Heart Failure for HFpEF detection — including performance data from JACC Advances, JASE, and Nature Communications. ▶️ Watch: https://t.co/cqCRgNre6P